Rezolute (RZLT) Income from Continuing Operations (2012 - 2026)

Rezolute's (RZLT) quarterly Income from Continuing Operations came in at 16171000.0 in Q1 2026, up 14.48% year-on-year from 14126184.71 in Q1 2025, and up 28.99% quarter-over-quarter from 22774000.0 in Q4 2025.

Rezolute (RZLT) Income from Continuing Operations (2012 - 2026) Analysis & Trends

Rezolute has disclosed Income from Continuing Operations across 15 years of filings, most recently posting 16171000.0 for Q1 2026.

  • Income from Continuing Operations for Q1 2026 came in at 16171000.0, up 14.48% year-over-year; the trailing twelve-month figure through Mar 2026 was 81485000.0 (down 13.07% YoY), and the FY2025 annual result was 74412000.0, down 13.51% from the prior year.
  • Income from Continuing Operations came in at 16171000.0 for Q1 2026 at Rezolute, up from 22774000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 9818000.0 in Q3 2022 to a low of 24405000.0 in Q2 2025.
  • The 5-year median for Income from Continuing Operations is 15363000.0 (2024), against an average of 15956176.47.
  • Across the five-year window, Income from Continuing Operations plunged 104.34% in 2022 and gained 14.48% in 2026, its largest moves.
  • Rezolute's Income from Continuing Operations stood at 13543000.0 in 2022, then declined by 2.57% to 13891000.0 in 2023, then fell by 13.28% to 15736000.0 in 2024, then plunged by 44.73% to 22774000.0 in 2025, then advanced by 28.99% to 16171000.0 in 2026.
  • The last three Income from Continuing Operations figures came in at 16171000.0 (Q1 2026), 22774000.0 (Q4 2025), and 18135000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -26.94 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -2.97 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 30.80 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -3.40 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -14.46 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -1.50 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 1.03 Bn
9 Abivax 91.96 Bn 91.96 Bn - -56.48 Mn
10 Rezolute 520.13 Mn 520.13 Mn - -16.17 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -16.17 Mn
Dec 31, 2025 -22.77 Mn
Sep 30, 2025 -18.14 Mn
Jun 30, 2025 -24.41 Mn
Mar 31, 2025 -18.91 Mn
Dec 31, 2024 -15.74 Mn
Sep 30, 2024 -15.36 Mn
Jun 30, 2024 -22.06 Mn
Mar 31, 2024 -15.09 Mn
Dec 31, 2023 -13.89 Mn
Sep 30, 2023 -14.51 Mn
Jun 30, 2023 -12.76 Mn
Mar 31, 2023 -15.66 Mn
Dec 31, 2022 -13.54 Mn
Sep 30, 2022 -9.82 Mn
Jun 30, 2022 -11.23 Mn
Mar 31, 2022 -11.20 Mn
Dec 31, 2021 -12.59 Mn
Sep 30, 2021 -8.08 Mn
Jun 30, 2021 -6.64 Mn